Bioluminescence imaging reveals dynamics of beta cell loss in the non-obese diabetic (NOD) mouse model.
We generated a mouse model (MIP-Luc-VU-NOD) that enables non-invasive bioluminescence imaging (BLI) of beta cell loss during the progression of autoimmune diabetes and determined the relationship between BLI and disease progression. MIP-Luc-VU-NOD mice displayed insulitis and a decline in biolumines...
Main Authors: | John Virostko, Armandla Radhika, Greg Poffenberger, Adrienne N Dula, Daniel J Moore, Alvin C Powers |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3590285?pdf=render |
Similar Items
-
Factors Influencing Quantification of in Vivo Bioluminescence Imaging: Application to Assessment of Pancreatic Islet Transplants
by: John Virostko, et al.
Published: (2004-10-01) -
Non-invasive bioluminescence imaging of β-cell function in obese-hyperglycemic [ob/ob] mice.
by: Manishkumar Patel, et al.
Published: (2014-01-01) -
Bioluminescent imaging in induced mouse models of endometriosis reveals differences in four model variations
by: Ashley Dorning, et al.
Published: (2021-08-01) -
Drug-induced loss of imprinting revealed using bioluminescent reporters of Cdkn1c
by: Andrew Dimond, et al.
Published: (2023-04-01) -
The NOD Mouse Beyond Autoimmune Diabetes
by: Anne-Marie Aubin, et al.
Published: (2022-04-01)